Answer to Question #217486 in Cell Biology for Srikanth Kodamasim

Question

A Person having renal carcinoma is undergoing chemotherapy where in the treatment is not effective as expected:
Based on the above scenario, what could be the probable reasons for the non-responsiveness of the patient to the therapy? (5 marks)
Suggest an alternative technology (animal models and cell models are not suitable) where in you can test a newer drug for managing the cancer patients (5 marks)
Suggest smart systems for targeted drug delivery (5 marks)
The above patient is diagnosed with tumor in the cortex region of the kidney. How this will affect the kidney function in the patient?

Answer 1

Smart drug delivery system (SDDS) is a recently emerging therapeutic approach, now turning into a conventional model to deliver drug to specific sites or target. Drug targeted (DT) delivery systems maintain the concentration of the drugs at desirable doses in the body and avoid the need for repeated doses.

Imaging tests allow your doctor to examine your bones and internal organs in a noninvasive way. Imaging tests used in diagnosing cancer may include a computerized tomography (CT) scan, bone scan, magnetic resonance imaging (MRI), positron emission tomography (PET) scan, ultrasound and X-ray, among others.